Page 207 - Read Online

Page 12 of 12 Tagliari et al. Vessel Plus 2020;4:16 I http://dx.doi.org/10.20517/2574-1209.2020.05

evaluated for percutaneous aortic valve insertion: preprocedural assessment with multidetector computed tomography. J Thorac
Cardiovasc Surg 2009;137:1258-64.
48. Perlman GY, Loncar S, Pollak A, Gilon D, Alcalai R, et al. Post-procedural hypertension following transcatheter aortic valve
implantation: incidence and clinical significance. JACC Cardiovasc Interv 2013;6:472-8.
49. Sato Y, Horiuchi Y, Yahagi K, Okuno T, Kusuhara T, et al. Simultaneous transcatheter aortic valve implantation and endovascular
aneurysm repair in a patient with very severe aortic stenosis with abdominal aortic aneurysm. J Cardiol Cases 2018;17:123-5.
50. Mauri S, Bozzani A, Ferlini M, Aiello M, Gazzoli F, et al. Combined transcatheter treatment of severe aortic valve stenosis and infrarenal
abdominal aortic aneurysm in increased surgical risk patients. Ann Vasc Surg 2019;60:480.e1-e5.
51. Natour M, Rabin A, Avraham E, Dannenberg C, Ronen Jaffe R, et al. Combined urgent transcatheter aortic valve implantation and
endovascular aneurysm repair for symptomatic abdominal aortic aneurysm. J Vasc Surg 2018;68:e140.
52. Komlo CM, Vallabhajosyula P, Bavaria JE, Desai ND, Anwaruddin S, et al. Combined transaortic transcatheter valve replacement and
thoracic endografting. Ann Thorac Surg 2014;97:696-8.
53. Rylski B, Szeto WY, Bavaria JE, Branchetti E, Moser W, et al. Development of a single endovascular device for aortic valve replacement
and ascending aortic repair. J Card Surg 2014;29:371-6.
54. Saadi EK, Tagliari AP, Almeida RMS. Endovascular treatment of the ascending aorta: is this the last frontier in aortic surgery? Braz J
Cardiovasc Surg 2020;34:759-64.
55. Attinger-Toller A, Maisano F, Senn O, Taramasso M, Shakir S, et al. “One-stop shop”: safety of combining transcatheter aortic valve
replacement and left atrial appendage occlusion. JACC Cardiovasc Interv 2016;9:1487-95.
56. Biviano AB, Nazif T, Dizon J, Garan H, Fleitman J, et al. Atrial fibrillation is associated with increased mortality in patients undergoing
transcatheter aortic valve replacement: insights from the placement of aortic transcatheter valve (PARTNER) trial. Circ Cardiovasc Interv
2016;9:e002766.
57. Nombela-Franco L, Webb JG, de Jaegere PP, Toggweiler S, Nuis RJ, et al. Timing, predictive factors, and prognostic value of
cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 2012;126:3041-53.
58. Yankelson L, Steinvil A, Gershovitz L, Leshem-Rubinow E, Furer A, et al. Atrial fibrillation, stroke, and mortality rates after transcatheter
aortic valve implantation. Am J Cardiol 2014;114:1861-6.
59. Stepinska J, Czerwinska K, Witkowski A, Dąbrowski M, Chmielak Z, et al. Risk factors for bleeding complications in patients undergoing
transcatheter aortic valve implantation (TAVI). Cardiol J 2013;20:125-33.
60. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for
prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42.
61. Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G,et al. Left atrial appendage closure with the Watchman Device in patients
with a contraindication for oral anticoagulation: the ASAP Study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage
Closure Technology). J Am Coll Cardiol 2013;61:2551-6.
62. Gafoor S, Heuer L, Franke J, Bertog S, Vaskelyte L, et al. Transcatheter aortic valve replacement and left atrial appendage occlusion - a
stitch in time? Interv Cardiol 2014;9:126-9.
63. Khattab AA, Gloekler S, Sprecher B, Shakir S, Guerios E, et al. Feasibility and outcomes of combined transcatheter aortic valve
replacement with other structural heart interventions in a single session: a matched cohort study. Open Heart 2014;1:e000014.
64. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med
2007;357:2262-8.
65. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, et al. Long-term outcomes of patent foramen ovale closure or medical
therapy after stroke. N Engl J Med 2017;377:1022-32.
66. Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after
stroke. N Engl J Med 2017;377:1011-21.
67. Taramasso M, Nietlispach F, Maisano F, Meier B. Patent foramen ovale: indications for closure and techniques. EuroIntervention
2016;12:X7-12.
68. Pasic M, Berger F, D'Ancona G, Dreysse S, Buz S, et al. Transcatheter aortic valve implantation and simultaneous closure of ostium
secundum atrial septal defect. Heart Surg Forum 2011;14:E354-6.
69. Bao L, Gao Q, Chen S, Chen Y, Elhmidi Y, et al. Feasibility and safety of combined percutaneous coronary intervention among high-
risk patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur J
Cardiothorac Surg 2018;54:1052-9.
70. Gilhofer TS, Obeid S, Luescher TF, Binder RK. Simultaneous transcatheter aortic valve implantation and left atrial appendage occlusion
versus both interventions as stand-alone procedures. Structural Heart 2018;2:492-7.